CitrusLabs is offering its services for free to organisations and researchers trying to find vaccines and drugs to treat Covid-19.  The company has helped with 200 clinical trials worldwide over the last five years. Founders Susanne Mitschke, Patrick Renner and Roger Arellano started the firm after seeing the effects of illness such as cognitive decline on loved ones.  Eighty-six per cent of clinical trials are held up by problems recruiting trial subjects. “Conditions like CovidD-19 affect so many of us, not only the sufferers but family, friends and the support systems around those suffering, and we want to be part of the team who find a vaccine and treatment.” The co-founders are graduates of the universities of Glasgow and Strathclyde. Their work has helped scientists researching treatments for Alzheimer’s disease, dementia and brain injury. CitrusLabs has raised $5 million from investors including 2048 Ventures, One Way Ventures, Mucker Capital and Launch Capital. Clients include Australian biotech firm Actinogen, University of Texas and the University of Washington.